{
  "containers": {
    "adp": [
      {
        "metrics": [
          {
            "other": {
              "content": {
                "id": "CVE-2026-101451",
                "options": [
                  {
                    "Exploitation": "none"
                  },
                  {
                    "Automatable": "no"
                  },
                  {
                    "Technical Impact": "total"
                  }
                ],
                "role": "CISA Coordinator",
                "timestamp": "2026-11-03T15:19:44.095941Z",
                "version": "2.0.3"
              },
              "type": "ssvc"
            }
          }
        ],
        "problemTypes": [
          {
            "descriptions": [
              {
                "cweId": "CWE-352",
                "description": "CWE-352 Cross-Site Request Forgery (CSRF)",
                "lang": "en",
                "type": "CWE"
              },
              {
                "cweId": "CWE-284",
                "description": "CWE-284 Improper Access Control",
                "lang": "en",
                "type": "CWE"
              }
            ]
          }
        ],
        "providerMetadata": {
          "dateUpdated": "2026-11-03T15:20:08.296Z",
          "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
          "shortName": "CISA-ADP"
        },
        "title": "CISA ADP Vulnrichment"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Siebel Life Sciences",
          "vendor": "Oracle Corporation",
          "versions": [
            {
              "lessThanOrEqual": "26.9",
              "status": "affected",
              "version": "17.0",
              "versionType": "custom"
            }
          ]
        }
      ],
      "cpeApplicability": [
        {
          "nodes": [
            {
              "cpeMatch": [
                {
                  "criteria": "cpe:2.3:a:oracle:siebel_life_sciences:*:*:*:*:*:*:*:*",
                  "versionEndIncluding": "26.9",
                  "versionStartIncluding": "17.0",
                  "vulnerable": true
                }
              ],
              "negate": false,
              "operator": "OR"
            }
          ]
        }
      ],
      "descriptions": [
        {
          "lang": "en-US",
          "value": "Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI).  Supported versions that are affected are 17.0-26.9. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences.  Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as  unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N)."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "NETWORK",
            "availabilityImpact": "NONE",
            "baseScore": 8.7,
            "baseSeverity": "HIGH",
            "confidentialityImpact": "HIGH",
            "integrityImpact": "HIGH",
            "privilegesRequired": "LOW",
            "scope": "CHANGED",
            "userInteraction": "REQUIRED",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N",
            "version": "3.1"
          }
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences.  Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in  unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as  unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data.",
              "lang": "en-US"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-10-20T21:20:55.232Z",
        "orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
        "shortName": "oracle"
      },
      "references": [
        {
          "name": "Oracle Advisory",
          "tags": [
            "vendor-advisory"
          ],
          "url": "https://www.oracle.com/security-alerts/cpuoct2026.html"
        }
      ]
    }
  },
  "cveMetadata": {
    "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
    "assignerShortName": "oracle",
    "cveId": "CVE-2026-101451",
    "datePublished": "2026-10-20T21:20:55.232Z",
    "dateReserved": "2026-09-28T15:40:09.483Z",
    "dateUpdated": "2026-11-03T15:20:08.296Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2"
}